Free discreet shipping across the EU · dispatch within 24 hCOA per batch · ≥99% HPLC
Research area

Peptides, energy and longevity

Cellular energy and biological ageing turn out to be the same conversation from two directions. Most of the compounds here are studied for what they do inside the mitochondrion, which is where both questions end up.

ISO-certified laboratoryCOA per batch, ≥99%Discreet 24h dispatchResearch use only
The mechanism

It all comes back to the mitochondrion

Mitochondria generate most of the cell’s usable energy, and they degrade in characteristic ways over time. That single fact is why a research area about energy and a research area about ageing keep converging on the same organelle and often the same molecules.

Three lines of work sit here. One concerns a coenzyme central to redox reactions, whose cellular levels change with age. Another concerns a peptide encoded in mitochondrial rather than nuclear DNA, which was only described relatively recently. A third concerns a short peptide studied for its interaction with a lipid specific to the inner mitochondrial membrane.

Two of those three are young fields with correspondingly thin literatures, and the compound pages say so rather than implying more certainty than exists.

What is being investigated
  • Redox balance and coenzyme availability
  • Peptides encoded in mitochondrial DNA
  • Cardiolipin interaction at the inner membrane
  • Which of these fields are genuinely young

Where this sits legally

SS-31 has been through clinical programmes under the name elamipretide. That is a different product from the research material here, with a different dossier behind it.

In this area

Compounds studied here

Six items spanning coenzymes, mitochondrial peptides and one enzyme inhibitor.

Where we stop

What this page leaves out

No promises about ageing, and no implication that a young field is a settled one. Two of the three research threads on this page are only a few years old, and the compound files say so in the first paragraph rather than the last. Nothing here describes an outcome in a person.

Frequently asked

Questions about this area

Usually about what counts as a peptide and what does not.

Is NAD+ a peptide?
No. It is a coenzyme, and it appears in peptide catalogues because of the research area rather than the chemistry. We keep the distinction visible rather than letting the category name imply something that is not true.
Why do energy and longevity share a page?
Because the literature does. Both keep arriving at mitochondrial function, and several compounds appear in papers from both directions. Splitting them would create two thin pages that link to the same studies.
How established is the MOTS-c research?
It is young. The peptide was described relatively recently and the body of work is correspondingly small. That is genuinely interesting from a research point of view and a poor basis for any confident claim, which is why the compound page says both things.
Why is 5-Amino-1MQ listed here rather than under weight?
Because the proposed mechanism is enzyme inhibition affecting cellular metabolism, which sits closer to this area than to receptor work on satiety. It is also not a peptide, which the individual file makes explicit.
Is there a difference between the NAD+ pen and the spray?
The route and the total content. Both are research formats and neither is presented as superior; which suits your work depends on what you are comparing.
Before you order

Young fields, described as such

Several of the compounds on this page sit in literatures only a few years old. We say that on the pages themselves rather than letting the catalogue imply otherwise.

For laboratory and research use only. Not for human or animal consumption. Not a medicine and not a food supplement. Sold to persons aged 18 and over. Compounds named on this page may appear on the WADA prohibited list.

Scroll naar boven